Status:
RECRUITING
Adjuvant VaccInation After Conization for the Treatment for CervicAL Dysplasia
Lead Sponsor:
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Conditions:
Cervical Intraepithelial Neoplasia
Eligibility:
FEMALE
18+ years
Brief Summary
HPV vaccination has emerged as a strategy to reduce the risk of recurrence oafter excisional treatment. However, only few data are aviable. In this trial the investigators aim to assess the role of HP...
Detailed Description
Patients treated for HPV-related disease are counseled about the potential protective role of HPV vaccination. The investigators will monitor the risk of HPV recurrence in pateints who choce to have v...
Eligibility Criteria
Inclusion
- Treatment of HPV-related disease
Exclusion
- Previous HPV vaccination
Key Trial Info
Start Date :
January 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 31 2027
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT06611020
Start Date
January 1 2020
End Date
January 31 2027
Last Update
September 26 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione IRCCS Istituto Nazionale dei Tumori
Milan, Lombardy, Italy, 20148
2
Fondazione IRCCS Istituto Nazionale dei Tumori
Milan, Lombardy, Italy, 20148